Microchimerism and scleroderma: An update

Current Rheumatology Reports

Volumn 5, Issue 2, 2003, Pages 154-159

  Artlett, Carol M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Graft Versus Host Disease; Human Leukocyte Antigen; Human Leukocyte Antigen Class; Scleroderma; Systemic Sclerosis

Indexed keywords

HLA ANTIGEN;

CHIMERA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; REVIEW; SYSTEMIC SCLEROSIS;

CHIMERA; FEMALE; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; PREGNANCY; SCLERODERMA, SYSTEMIC;

EID: 0038044586     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-003-0044-2     Document Type: Article

References (39)

1. Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Eng J Med 1998, 338:1186–1191. This paper is a seminal publication that demonstrates, for the first time, the presence of fetal microchimeric cells in the active lesions of patients with SSc, and also that microchimeric cells in the peripheral blood are CD3+ T cells. DOI: 10.1056/NEJM199804233381704
2. Artlett CM, Cox LA, Ramos RC, et al.: Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol 2002, 103:303–308. This paper identifies the presence of fetal microchimeric cells in the CD4+ T cell population in peripheral blood. CD4+ T cells are important effector molecules in mediating GVHD. This article adds support to the hypothesis that SSc may be a GVHD mediated disease. DOI: 10.1006/clim.2002.5222
3. Artlett CM, Welsh KI, Black CM, Jimenez SA: Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997, 47:17–22. This article is the first report of HLA class II compatibility between SSc patients and offspring and their mothers DOI: 10.1007/s002510050321
4. Nelson JL, Furst DE, Maloney S, et al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559–562. This publication confirms the Artlett et al. [3] study by demonstrating HLA compatibility in SSc families; it also demonstrates microchimeric cells in the peripheral blood of women with SSc. DOI: 10.1016/S0140-6736(97)08357-8
5. Artlett CM: Microchimerism in health and disease. Curr Molec Med 2002, 2:525–535. DOI: 10.2174/1566524023362131
6. Artlett CM, Smith JB, Jimenez SA: New perspectives on the etiology of systemic sclerosis. Molec Med Today 1999, 5:74–78. DOI: 10.1016/S1357-4310(98)01405-1
7. McCormick LL, Zhang Y, Tootell E, Gilliam AC: Anti-TGF-b treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999, 163:5693–5699.
8. Zhang Y, McCormick LL, Desai SR, et al.: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088–3098. This article investigates and demonstrates the importance of the murine sclerodermatous GVHD as a model for SSc.
9. Evans PC, Lambert N, Maloney S, et al.: Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033–2037.
10. Lambert NC, Evans PC, Hashizumi TL, et al.: Persistent fetal microchimerism in T lymphocytes is associated with HLADQA1* 0501: implications in autoimmunity. J Immunol 2000, 164:5545–5548.
11. Artlett CM, Sawaya HHB, Russo-Stieglitz KE, et al.: Persistent microchimerism is not associated with HLA-DQA1 in systemic sclerosis or juvenile myositis [manuscript submitted for publication]. Journal 2003, In press.
12. Moudgil KD, Sercarz EE: The self-directed T cell repertoire: its creation and activation. Rev Immunogenet 2000, 2:26–37.
13. Sakkas LI, Xu B, Artlett CM, et al.: Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002, 168:3649–3659.
14. Gaschet J, Trevino MA, Cherel M, et al.: HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during graft-versus-host disease. Blood 1996, 87:2345–2353.
15. Schultz KR, Paquet J, Bader S, HayGlass KT: Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant 1995, 16:289–295.
16. Datta AR, Barrett AJ, Jiang YZ, et al.: Distinct T cell populations distinguish chronic myeloid leukemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions. Bone Marrow Transplant 1994, 14:517–524.
17. Murata H, Nakauchi H, Sumida T: Microchimerism in Japanese women patients with systemic sclerosis. Lancet 1999, 354:220–220. DOI: 10.1016/S0140-6736(99)00164-6
18. Miyashita Y, Ono M, Ueki H, Kurasawa K: Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 2000, 59:655–656. DOI: 10.1136/ard.59.8.654b
19. Ichikawa N, Kotake S, Hakoda M, Kamatani N: Microchimerism in Japanese patients with systemic sclerosis. Arthritis Rheum 2001, 44:1226–1228. DOI: 10.1002/1529-0131(200105)44:5<1226::AID-ANR208>3.0.CO;2-Q
20. Lo YMD: Non-invasive prenatal diagnosis using fetal cells in maternal blood. J Clin Pathol 1994, 47:1060–1065. DOI: 10.1136/jcp.47.12.1060
21. Lo YMD, Lau TK, Chan LYS, et al.: Quantitative analysis of bi-directional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000, 46:1301–1309.
22. Thomson AW, Lu L, Wan Y, et al.: Identification of donorderived dendritic cells progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 1995, 60:1555–1559. DOI: 10.1097/00007890-199560120-00030
23. Martin WL, Durrant LG, Liu DTY: Non-invasive fetal cell isolation from maternal blood. Br J Obstet Gynecol 1998, 105:576–583.
24. Cox LA, Ramos RC, Dennis TN, et al.: Detection of microchimeric cells in the peripheral blood of non-pregnant women is enhanced by magnetic cell sorting prior to PCR. Arthritis Rheum 2003, In press.
25. Ohtsuka T, Miyamoto Y, Yamakage A, Yamazaki S: Quantitative analysis of microchimerism in systemic sclerosis tissue. Arch Dermatol Res 2001, 293:387–391. This article reports that SSc lesions have increased numbers of fetal microchimeric cells compared with other autoimmune diseases and control individuals. DOI: 10.1007/s004030100245
26. Scaletti C, Vultaggio A, Bonifacio S, et al.: TH2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002, 46:445–450. This paper was the first to demonstrate that male fetal cells actively recognize the HLA alleles from patients with SSc, use mixed lymphocyte reactiona, and that these cells produce an abundance of interleukin-4. DOI: 10.1002/art.10049
27. Artlett CM, Sawaya HHB, Johnson-Hopson CN, et al.: Microchimeric cells identified by immunophenotyping and fluorescence in situ hybridization in active lesions from patients with systemic sclerosis are activated T cells. Arthritis Rheum 2003, In press. This abstract investigates the phenotypes of the microchimeric cells in the active lesions of patients with SSc and that these cells are activated T cells.
28. Tanei R, Yamamoto T, Yokono H, Motoori T: Scaling lichenoid eruptions and Sjogren-like syndrome: manifestations of nonfatal postoperative transfusion-associated graft-versushost disease. J Dermatol 1997, 24:514–521.
29. Srivasta B, Srivasta S, Johnson KL, et al.: Microchimerism of presumed fetal origin in thyroid specimens from women: a case controlled study. Lancet 2001, 358:2034–2038. DOI: 10.1016/S0140-6736(01)07099-4
30. Ferrari G, Cusella-De Angelis G, Coletta M, et al.: Muscle regenaretion by bone-marrow derived myogenic progenitors. Science 1998, 279:1528–1530. DOI: 10.1126/science.279.5356.1528
31. Morrison SJ: Stem cell potential: can anything make anything? Curr Biology 2001, 11:R7-R9. DOI: 10.1016/S0960-9822(00)00033-6
32. Bjornson CRR, Rietze RL, Reynolds BA, et al.: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999, 283:534–537. DOI: 10.1126/science.283.5401.534
33. Anderson DJ, Gage FH, Weissman IL: Can stem cells cross lineage boundaries? Nat Med 2001, 7:393–395. This paper reviews the current concepts of cells crossing lineage boundaries by transdifferention via genomic reprogramming. DOI: 10.1038/86439
34. Klintschar M, Schwaiger P, Mannweiler S, et al.: Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2001, 86:2494–2498. DOI: 10.1210/jc.86.6.2494
35. Aractingi S, Sibilia J, Meignin V, et al.: Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjogren’s syndrome. Arthritis Rheum 2002, 46:1039–1043. Identification of microchimeric cells in the salivary glands of patients with SSc, but not in patients with Sjögren’s syndrome. DOI: 10.1002/art.10137
36. Endo Y, Negishi I, Ishikawa O: Possible contribution of microchimerism to the pathogenesis of Sjögren’s syndrome. Rheumatology 2002, 41:490–495. DOI: 10.1093/rheumatology/41.5.490
37. Pisa FE, Bovenzi M, Romeo L, et al.: Reproductive factors and the risk of scleroderma. Arthritis Rheum 2002, 46:451–456. DOI: 10.1002/art.10178
38. Artlett CM, Rasheed M, Russo-Stieglitz KE, et al.: Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis 2002, 61:346–350. DOI: 10.1136/ard.61.4.346
39. Launay D, Hebbar M, Hatron PY, et al.: Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol 2001, 28:509–513.